Suction of AstraZeneca vaccine: Security Experts Gather

Vaccinator safety experts from the World Health Organisation (OBSH) will meet today to review the Oxford-AstraZeneca vaccine, as several European countries banned the use. There have been a number of cases in Europe of blood clotting that developed after taking the vaccine. However, experts say the number of incidents coincides with the [...] rate.
There have been a number of cases in Europe of blood clotting that developed after taking the vaccine.
However, experts say the number of incidents coincides with the usually reported rate in the general population.
The European Bars Agency (EMA) will also hold a meeting. A decision is expected to be issued on the continued use of the Oxford-AstraZeneca vaccine on Thursday.
About 17 million people in the EU and the United Kingdom have received a dose of the vaccine, with less than 40 cases of blood clotting reported since last week, AstraZeneca said.
Untested claims that there may be a link have led to 11 European countries suspending the use of the vaccine, including Germany, France, Italy and Spain.
Other countries, including Austria, have banned the use of specific groups as a precautionary measure.
However, Belgium, Poland, the Czech Republic and Ukraine said they would continue managing the AstraZeneca vaccine. And in Thailand, Prime Minister Prymouth Chan-ocha became the first person instead of taking the AstraZeneca vaccine.











